Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
In 144 healthy adults with MD, males presented lower adherence to the MD, higher energy intake and higher TMAO levels than females (Barrea et al., 2019)
The subcutaneous dosing regimen results in more pronounced DPP-IV inhibition as compared to oral dosing in DIO mice (~ 80% inhibition) 28
were supported by a National Institutes of Health Kidney Specialized Programs of Research Excellence (SPORE) (P50CA196516)
The actual steady-state monthly cost ranges from $129 a month (oral tirzepatide, 12-month plan) up to $449 a month (tirzepatide, 1-month plan), depending entirely on which formulation and plan length you pick
US$ 23.66
US$ 25.85
US$ 23.75
US$ 27.22
US$ 21.20
